https://biotechmorning.com/news/janux-double-masked-t-cell-engager Biotech Morning en 2026-04-18T14:08:57.191Z The Cancer Drug Designed to Ignore Everything Except the Tumor https://biotechmorning.com/news/ucb-neurona-epilepsy-cell-therapy-acquisition Biotech Morning en 2026-04-18T14:08:13.557Z UCB Just Dropped $1.15 Billion on a Brain Cell Transplant for Epilepsy https://biotechmorning.com/news/cerebras-2-billion-ipo-bet-against-nvidia Biotech Morning en 2026-04-18T14:07:27.377Z The Bet Against Nvidia's AI Monopoly https://biotechmorning.com/news/roivant-ceo-china-biotech-red-herring Biotech Morning en 2026-04-18T14:06:47.986Z Roivant's CEO Says We're All Worried About the Wrong Thing https://biotechmorning.com/news/merck-secret-weapon-life-after-keytruda Biotech Morning en 2026-04-18T14:06:10.714Z Merck's Secret Weapon for Life After Keytruda https://biotechmorning.com/news/openai-gpt-rosalind-biotech-drug-discovery Biotech Morning en 2026-04-18T14:05:27.589Z OpenAI Just Built an AI That Speaks Fluent Biology https://biotechmorning.com/news/fda-bone-growth-stimulator-reclassification Biotech Morning en 2026-04-17T14:13:55.272Z The FDA Just Made It Way Easier to Sell a Bone-Healing Device https://biotechmorning.com/news/aligos-amoytop-china-hbv-deal Biotech Morning en 2026-04-17T14:13:13.091Z Aligos Just Sold Half the Map for $445 Million https://biotechmorning.com/news/terremoto-akt-inhibitor-358m-bet Biotech Morning en 2026-04-17T14:12:28.595Z The $358M Bet on a Cancer Target That Keeps Breaking Hearts https://biotechmorning.com/news/kailera-therapeutics-biggest-biotech-ipo-obesity Biotech Morning en 2026-04-17T14:11:46.388Z A Record Biotech IPO Just Bet $625M on Your Waistline https://biotechmorning.com/news/pancreatic-cancer-finally-blinked Biotech Morning en 2026-04-17T14:11:01.079Z The Cancer That Finally Blinked https://biotechmorning.com/news/alzheimers-anti-amyloid-drugs-trivial-benefits-report Biotech Morning en 2026-04-17T14:10:21.686Z The $6 Billion Question: Do Alzheimer's Blockbuster Drugs Actually Work? https://biotechmorning.com/news/beeline-medicines-300m-launch-bms-autoimmune Biotech Morning en 2026-04-17T14:09:36.186Z Bristol Myers Squibb Just Gave Away Five Drugs. One Startup Got Them All. https://biotechmorning.com/news/meiragtx-reacquires-eye-gene-therapy-jj Biotech Morning en 2026-04-17T14:08:48.314Z J&J Spent $415 Million on This Eye Gene Therapy. MeiraGTx Just Bought It Back for $25 Million. https://biotechmorning.com/news/storm-therapeutics-series-c-epitranscriptomics-sarcoma Biotech Morning en 2026-04-17T14:08:03.448Z The Biotech Field That Didn't Exist a Decade Ago Just Got Its Biggest Bet Yet https://biotechmorning.com/news/first-fsgs-drug-filspari-approved Biotech Morning en 2026-04-17T14:07:18.545Z The First-Ever Drug for a Kidney Disease That Destroys 50% of Patients